Vitasora HealthASX:VHL PB Ratio is 1.44 as of Jul. 11, 2026, which is 46% below its 10-year median of 2.67. The stock has 6 warning signs investors should review. Among 608 Healthcare Providers & Services companies, Vitasora Health ranks better than 63.49% on this metric.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2026-07-11), Vitasora Health's share price is A$0.013. Vitasora Health's Book Value per Share for the quarter that ended in Dec. 2025 was A$0.01. Hence, Vitasora Health's PB Ratio of today is 1.44.
The historical rank and industry rank for Vitasora Health's PB Ratio or its related term are showing as below:
ASX:VHL'
s PB Ratio Range Over the Past 10 Years
Min: 1.11 Med: 2.67 Max: 3.56
Current: 1.44
During the past 13 years, Vitasora Health's highest PB Ratio was 3.56. The lowest was 1.11. And the median was 2.67.
ASX:VHL's PB Ratio is ranked better than 63.49% of 608
companies
in the Healthcare Providers & Services industry
Industry Median: 1.99
vs ASX:VHL: 1.44
During the past 12 months, Vitasora Health's average Book Value Per Share Growth Rate was 125.00% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was 31.00% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was -6.00% per year.
During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of Vitasora Health was 49.40% per year. The lowest was -82.60% per year. And the median was -38.50% per year.
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
Vitasora Health PB Ratio Related Terms
Vitasora Health PB Ratio Historical Data
* Premium members only.
The historical data trend for Vitasora Health's PB Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Health Information Services subindustry, Vitasora Health's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Vitasora Health PB Ratio vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Vitasora Health's PB Ratio distribution charts can be found below:
* The bar in red indicates where Vitasora Health's PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
Vitasora Health's PB Ratio for today is calculated as follows:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
Vitasora Health (ASX:VHL) has a PB Ratio of 1.44 as of Jul. 11, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Vitasora Health and its competitors. This is 46% below median its historical median of 2.67. Over the past decade, Vitasora Health's PB Ratio has ranged from 1.11 to 3.56. According to the industry distribution chart, Vitasora Health ranks #222 out of 608 companies in the Healthcare Providers & Services industry, placing it in the top 36.5%.
Is Vitasora Health's PB Ratio too high?
Vitasora Health's current PB Ratio of 1.44 is 46% below median its 10-year median of 2.67. Over the past 10 years, this metric has ranged from a low of 1.11 to a high of 3.56. The Healthcare Providers & Services industry median PB Ratio is 1.99. Vitasora Health's value of 1.44 is 27.6% below this industry median. Based on the distribution chart, Vitasora Health ranks #222 out of 608 companies in the Healthcare Providers & Services industry, which is above the industry midpoint.
How does Vitasora Health's PB Ratio compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Vitasora Health ranks #222 out of 608 companies for PB Ratio. This puts Vitasora Health in the upper half of its industry. The industry median PB Ratio is 1.99. Vitasora Health's value of 1.44 is 27.6% below this benchmark. Historically, Vitasora Health's own PB Ratio has ranged from 1.11 to 3.56 over the past decade. While the company's 10-year median is 2.67 vs. the industry median of 1.99, Vitasora Health has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Healthcare Providers & Services company?
The median PB Ratio among Healthcare Providers & Services companies is 1.99, based on 608 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Vitasora Health's current PB Ratio of 1.44 is 27.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Vitasora Health and its competitors. For the Healthcare Providers & Services industry, the median PB Ratio is 1.99 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Vitasora Health's current PB Ratio is 1.44, which is 46% below median its own 10-year median of 2.67. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vitasora Health stock overvalued right now?
Vitasora Health (ASX:VHL) has a current PB Ratio of 1.44. The current PB Ratio is 1.44, which is 46% below median its 10-year median of 2.67 and 27.6% below the Healthcare Providers & Services industry median of 1.99. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For Vitasora Health (ASX:VHL), the current PB Ratio is 1.44 as of Jul. 11, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Vitasora Health Ltd is engaged in healthcare technology and services, providing critical patient health tracking services to clinicians and healthcare teams. Through data-driven programs, clinical technology, and support tools, it enables healthcare professionals to extend the capacity of care beyond the clinic. The company operates in Australia and the USA, with the majority of its revenue coming from the USA. The United States reportable segment, through the acquisition of Access Telehealth and Orb Health, provides reportable segment activities such as a broader value proposition and solutions for managing the majority chronic disease states, including Cardiovascular, Diabetes, Chronic Obstructive Pulmonary Disease (COPD), and Obesity.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:VHL has been successfully added to your 